Sustained virologic response and relapse rates in treatment-naive Caucasian patients with HCV genotype 3 by baseline prediction score.

Abstract

<p>A) Development cohort; B) Validation cohort SVR = sustained virologic response 24 weeks post-treatment. ^a 73 patients did not have a score and were omitted; of these, 46 (63.0%) achieved SVR. ^b Patients with end-of-treatment response and sufficient follow-up.</p